Utah Medical Products raises dividend to $.305 per share

SALT LAKE CITY - Utah Medical Products, Inc. (NASDAQ:UTMD) announced today that its Board of Directors has approved an increase in its quarterly cash dividend. The payment, set at thirty and one-half cents ($.305) per share of common stock, represents a 1.7% rise from the dividend declared in the same quarter of the previous year. Stockholders on record by the close of business on June 16, 2025, will be eligible for the dividend, which is scheduled to be paid on July 3, 2025. This increase maintains the company’s impressive 22-year streak of consistent dividend payments, with the current yield standing at 2.33%.

Utah Medical Products, Inc. specializes in healthcare products for women and their babies, developing, manufacturing, and marketing a wide array of disposable and reusable specialty medical devices. These products are recognized by healthcare professionals in over a hundred countries globally as essential for achieving optimal long-term outcomes for patients. According to InvestingPro data, the company maintains strong profitability with a gross margin of 58.35% and generates healthy returns with a 10.05% return on assets.

The increment in the dividend payout reflects the company’s commitment to providing value to its shareholders and its confidence in the ongoing financial health and stability of the business. Dividend decisions are typically seen as indicators of a company’s performance and management’s expectations for future profitability. InvestingPro analysis reveals several positive indicators, including the company holding more cash than debt and maintaining strong liquidity with a current ratio of 22.29. Subscribers can access 8 additional ProTips and comprehensive financial metrics for deeper analysis.

The announcement comes as part of Utah Medical Products’ broader strategy to maintain a position of strength in the healthcare market, particularly in the niche of medical devices for women and newborn care. The company’s products are well-regarded in the medical community, and its financial decisions, including dividend distributions, are closely watched by investors and analysts alike. The stock currently trades at a P/E ratio of 13.68 and, based on InvestingPro’s Fair Value analysis, appears undervalued in the current market.

This dividend increase is based on a press release statement from Utah Medical Products, Inc. It is a key piece of information for investors, as dividends are a significant component of investment returns. The company’s ability to consistently pay and raise dividends can be a favorable sign to the market, often interpreted as a signal of a company’s strong financial health and management’s confidence in future cash flows.

Investors and market observers often look to such announcements to gauge the financial health and strategic direction of companies like Utah Medical Products, Inc. The announcement does not include any forward-looking statements or promises about the company’s future performance but is a factual representation of the Board’s decision regarding this quarter’s dividend distribution.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.